{"entity":{"type":"insider","cik":"0001772491","url":"/insider/0001772491","json_url":"/insider/0001772491.json","name":"Altiva Management Inc.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2019-08-27","last":"2019-09-11","span_basis":"filed_date"},"name_variants":[{"name":"Altiva Management Inc.","source":"filing","n_filings":3,"first_seen":"2019-08-27","last_seen":"2019-09-11"}],"transactions":[{"id":8279287,"accession":"0000921895-19-002393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-19-002393","line_url":"/filing/0000921895-19-002393#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":null,"owner_name":"Velan Capital, L.P.; Altiva Management Inc.; VENKATARAMAN BALAJI","owner_display_name":"Velan Capital, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.0013 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72023.0,"shares_display":"72,023","price_per_share":4.9947,"price_display":"4.99","price_state":"stated","total_value":359733.2781,"total_display":"359,733.28","total_whole":"359,733","shares_owned_after":8011733.0,"shares_owned_after_display":"8,011,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-11","scope":"insider"},{"id":7941305,"accession":"0000921895-19-002367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-19-002367","line_url":"/filing/0000921895-19-002367#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":null,"owner_name":"Velan Capital, L.P.; Altiva Management Inc.; VENKATARAMAN BALAJI","owner_display_name":"Velan Capital, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.0013 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":243614.0,"shares_display":"243,614","price_per_share":4.5093,"price_display":"4.51","price_state":"stated","total_value":1098528.6102,"total_display":"1,098,528.61","total_whole":"1,098,529","shares_owned_after":7939710.0,"shares_owned_after_display":"7,939,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-05","scope":"insider"},{"id":7941300,"accession":"0000921895-19-002367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-19-002367","line_url":"/filing/0000921895-19-002367#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":null,"owner_name":"Velan Capital, L.P.; Altiva Management Inc.; VENKATARAMAN BALAJI","owner_display_name":"Velan Capital, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.0013 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277424.0,"shares_display":"277,424","price_per_share":4.3937,"price_display":"4.39","price_state":"stated","total_value":1218917.8288,"total_display":"1,218,917.83","total_whole":"1,218,918","shares_owned_after":7696096.0,"shares_owned_after_display":"7,696,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-03","filed_date":"2019-09-05","scope":"insider"},{"id":8051725,"accession":"0000921895-19-002346","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-19-002346","line_url":"/filing/0000921895-19-002346#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":null,"owner_name":"VENKATARAMAN BALAJI; Velan Capital, L.P.; Altiva Management Inc.","owner_display_name":"VENKATARAMAN BALAJI","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.0013 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73230.0,"shares_display":"73,230","price_per_share":4.3003,"price_display":"4.30","price_state":"stated","total_value":314910.969,"total_display":"314,910.97","total_whole":"314,911","shares_owned_after":7418672.0,"shares_owned_after_display":"7,418,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-27","scope":"insider"},{"id":8051720,"accession":"0000921895-19-002346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000921895-19-002346","line_url":"/filing/0000921895-19-002346#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":null,"owner_name":"VENKATARAMAN BALAJI; Velan Capital, L.P.; Altiva Management Inc.","owner_display_name":"VENKATARAMAN BALAJI","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.0013 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":130826.0,"shares_display":"130,826","price_per_share":4.3087,"price_display":"4.31","price_state":"stated","total_value":563689.9862,"total_display":"563,689.99","total_whole":"563,690","shares_owned_after":7345442.0,"shares_owned_after_display":"7,345,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2019-08-27","last_seen":"2019-09-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001772491","retrieved_at":"2026-08-22T12:36:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}